India rules out TRIPS-plus measures and superseding of domestic laws in EU FTA
This article was originally published in Scrip
Executive Summary
If the UK royal wedding lifted spirits and perhaps to some extent the British economy over the weekend, the Indian Prime Minister's Office (PMO) brought some muted cheer and a sense of relief to the Indian pharma industry and patient groups, albeit for altogether different reasons.